This protocol is judged by an institutional assessment board, an impartial team that evaluations any medical trials involving individuals. If a study includes a Agenda I drug, as soon as the board approves the protocol as moral, the scientists need to make an application for an investigational new drug (IND) quantity from your FDA.Some scientists